Gossamer Bio, Inc. (GOSS)
Track the next or latest earnings date for Gossamer Bio, Inc., review consensus estimates, and see cached AI analysis for recent quarterly results.
Recent earnings news
finance.yahoo.com · 9 hours ago
In the closing of the recent trading day, Canada Goose (GOOS) stood at $9.72, denoting a +1.36% move from the preceding trading day.
Are Finance Stocks Lagging The Goldman Sachs Group (GS) This Year?finance.yahoo.com · 17 hours ago
Here is how Goldman Sachs (GS) and Abacus Global Management, Inc. (ABX) have performed compared to their sector so far this year.
GOSS: Gossamer Bio Sets Initial Conversion Rate for Convertible Noteswww.gurufocus.com · 6 days ago
Calendar & Research Financial Calendar Earnings Calendar & Reports Analyst Ratings Fund Letters Archive Transcripts Search Stock Market Holidays ... On July 01, 2026, Gossamer Bio Inc GOSS announced the initial conversion rate for its 7.50% priority secured convertible notes maturing in 2030, ...
Buy Gossamer Bio Inc Stock – GOSS Stock Quote Today & Investment Insights - Public.compublic.com · Recent
Looking to buy Gossamer Bio Inc Stock? Get the latest GOSS quote, news, earnings, forecast, price targets, and market insights. Start investing on Public.com.
Gossamer Bio (NASDAQ: GOSS) sets note conversion rate and warrant exercise pricewww.stocktitan.net · 6 days ago
Gossamer Bio fixes its 7.50% 2030 note conversion at 5,347.5936 shares per $1,000 and sets Purchase Warrant exercise price at $0.34 per share, based on a $0.17 Reference Price.
Latest earnings date
Time not specified
Fiscal quarter: 2025-12-31
EPS estimate: -$0.20
Revenue estimate: N/A
Market cap: $109.20M
Analysis snapshot
No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.
Recent earnings history
Browse the calendar week| Date | Quarter | Report window | EPS est. | Revenue est. |
|---|---|---|---|---|
| Mar 17, 2026 | 2025-12-31 | Time not specified | -$0.20 | N/A |